Technical analysis of Entrada Therapeutics, Inc. (TRDA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches.
Price Performance
| 1 month | -5.23% |
| 3 months | -2.82% |
| Year-to-date | -32.98% |
| 1 year | +35.36% |
| 3 years | -51.89% |
52-Week Range
| 52-week High | $16.45 |
| 52-week Low | $5.02 |
| Avg Volume (90d) | 385K |
Technical Indicators
| SMA 50 | $6.98 |
| SMA 200 | $9.58 |
| Beta | -0.15 |
| 30-day Volatility (annualised) | 65.5% |
| Price vs SMA 50 | -1.2% |
| Price vs SMA 200 | -28.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $6.95 | |
| 2025-11 | $10.27 | +47.8% |
| 2025-12 | $10.28 | +0.1% |
| 2026-01 | $11.44 | +11.3% |
| 2026-02 | $11.93 | +4.3% |
| 2026-03 | $12.62 | +5.8% |
| 2026-04 | $13.50 | +7.0% |
| 2026-05 | $7.07 | -47.6% |
| 2026-06 | $7.36 | +4.1% |
| 2026-07 | $6.79 | -7.7% |
| 2026-08 | $7.05 | +3.8% |
| 2026-09 | $6.89 | -2.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $6.89 |
| Market Cap | $267M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.22 |
| EV / EBITDA | -1.37 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.21 |
| Current Ratio | 10.89 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 2.17 |